NCT06855953View on ClinicalTrials.gov

Vitamin K and Cognition in Coronary Heart Disease (NutriCog)

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions
Coronary Heart Disease
Interventions
DIETARY_SUPPLEMENT

Vitamin K

Participants receive 0.5 mg/day phylloquinone orally for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Participants receive daily placebo for 12 weeks

Trial Locations (1)

H1T 1C8

Montreal Heart Institute, Montreal

All Listed Sponsors
lead

Montreal Heart Institute

OTHER

NCT06855953 - Vitamin K and Cognition in Coronary Heart Disease (NutriCog) | Biotech Hunter | Biotech Hunter